کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5902840 1156860 2015 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy
ترجمه فارسی عنوان
از دستورالعمل به بیمار: بررسی توصیه های اخیر برای داروی درمان نوروپاتی دردناک دیابتی
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی علوم غدد
چکیده انگلیسی
Painful diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus, affecting, by some estimates, up to one quarter of diabetic patients. Since 2010, no fewer than 5 major international treatment guidelines for painful DPN have been issued, and there are meaningful differences among them. Duloxetine, pregabalin, gabapentin, and tricyclic antidepressants are the mainstays of treatment, but the choice of which class or agent to use in any given patient should be informed by patient characteristics. This review seeks to describe the differences among the recently issued guidelines, to assess the evidence on which they are based, and to offer insight into the most appropriate treatment choices based on patient characteristics.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Diabetes and its Complications - Volume 29, Issue 1, January–February 2015, Pages 146-156
نویسندگان
, ,